Pharma > Communications to Healthcare Professionals

IDA

OGILVY HEALTHWORLD, London / ASTRAZENECA / 2016

CampaignCampaignLayout(opens in a new tab)
Supporting Content
Digital Proof JPG

Overview

Credits

Overview

Audience

Primary and secondary care physicians treating patients diagnosed with Type 2 diabetes in various healthcare settings. Our primary audience consists of healthcare professionals new to using SGLT2 inhibitors (the category of drugs FORXIGA belongs to). The secondary audience consists of physicians already prescribing FORXIGA.

BriefWithProjectedOutcomes

FORXIGA and XIGDUO (FORXIGA+metformin) are prescription drugs that may only be advertised to healthcare professionals. They are promoted by AstraZeneca, whose headquarters are in the UK. As such, they must follow the ABPI Code of Practice, which requires materials to be appropriate, factual, fair and capable of substantiation.

EntrySummary

It was mandated by the client that our campaign imagery utilised an existing global visual asset (the‘sugar shaker’ visual). This campaign was designed from a global perspective and tested via market research in key markets around the world, to ensure global creative resonation and universal cultural accessibility, whilst still providing countries with the ability to adapt the end material type and content to best fit their local needs.

Translation

n/a

More Entries from Pharma, Vaccines & Biotech - Branded Communication in Pharma

24 items

Grand Prix Cannes Lions
BREATHLESS CHOIR

Devices & Diagnostics

BREATHLESS CHOIR

PHILIPS, OGILVY & MATHER LONDON

(opens in a new tab)

More Entries from OGILVY HEALTHWORLD

24 items

Silver Cannes Lions
TOUCHING DIABETES PATIENTS' LIVES

Pharma, Vaccines & Biotech - Branded Communication

TOUCHING DIABETES PATIENTS' LIVES

ASTRAZENECA, OGILVY HEALTHWORLD

(opens in a new tab)